KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Deffered Revenue (2018 - 2025)

Adaptive Biotechnologies' Non-Current Deffered Revenue history spans 8 years, with the latest figure at $1.0 million for Q4 2025.

  • For Q4 2025, Non-Current Deffered Revenue fell 96.31% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, down 96.31%, while the annual FY2025 figure was $1.0 million, 96.31% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $1.0 million at Adaptive Biotechnologies, down from $1.2 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $144.4 million in Q1 2021 and bottomed at $1.0 million in Q4 2025.
  • The 5-year median for Non-Current Deffered Revenue is $47.8 million (2023), against an average of $57.1 million.
  • The largest annual shift saw Non-Current Deffered Revenue fell 18.08% in 2024 before it plummeted 96.32% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $98.8 million in 2021, then plummeted by 40.66% to $58.6 million in 2022, then decreased by 23.56% to $44.8 million in 2023, then crashed by 39.15% to $27.3 million in 2024, then plummeted by 96.31% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Non-Current Deffered Revenue are $1.0 million (Q4 2025), $1.2 million (Q3 2025), and $20.0 million (Q2 2025).